Terms: = Endocrine gland cancer AND TSC1, KIAA0243, 7248, ENSG00000165699, TSC, MGC86987, LAM, hamartin AND Treatment
24 results:
1. Tuberous sclerosis complex mutations in patients with pancreatic neuroendocrine tumors. Observations on phenotypic and treatment-related associations.
Navale P; Chatterjee D; Itani M; Trikalinos NA
Virchows Arch; 2023 Aug; 483(2):167-175. PubMed ID: 37354253
[TBL] [Abstract] [Full Text] [Related]
2. A systems biology approach to define mechanisms, phenotypes, and drivers in PanNETs with a personalized perspective.
Werle SD; Ikonomi N; Lausser L; Kestler AMTU; Weidner FM; Schwab JD; Maier J; Buchholz M; Gress TM; Kestler AMR; Kestler HA
NPJ Syst Biol Appl; 2023 Jun; 9(1):22. PubMed ID: 37270586
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy and safety of anlotinib-based chemotherapy for locally advanced or metastatic anaplastic thyroid carcinoma.
Zheng X; Wang J; Ye T; Tang W; Pan X; Wang S; Liu J
Endocrine; 2023 Sep; 81(3):540-546. PubMed ID: 37219702
[TBL] [Abstract] [Full Text] [Related]
4. Turning up the heat on non-immunoreactive tumors: autophagy influences the immune microenvironment in pancreatic cancer.
Lu SY; Hua J; Liu J; Wei MY; Liang C; Meng QC; Zhang B; Yu XJ; Wang W; Xu J
BMC Med Genomics; 2022 Oct; 15(1):218. PubMed ID: 36261830
[TBL] [Abstract] [Full Text] [Related]
5. Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies.
Ruggeri RM; Benevento E; De Cicco F; Fazzalari B; Guadagno E; Hasballa I; Tarsitano MG; Isidori AM; Colao A; Faggiano A;
J Endocrinol Invest; 2023 Feb; 46(2):213-234. PubMed ID: 36038743
[TBL] [Abstract] [Full Text] [Related]
6. Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast cancer or Ovarian cancer, 2012-2019.
Kurian AW; Ward KC; Abrahamse P; Bondarenko I; Hamilton AS; Deapen D; Morrow M; Berek JS; Hofer TP; Katz SJ
J Clin Oncol; 2021 May; 39(15):1631-1640. PubMed ID: 33560870
[TBL] [Abstract] [Full Text] [Related]
7. Ultrasound-guided percutaneous microwave ablation assisted by a three-dimensional visualization preoperative treatment planning system for larger adrenal metastasis (D ≥ 4 cm): Preliminary results.
Wu S; Li X; Yu J; Yu X; Cheng Z; Liu F; Han Z; Duan S; Liang P
J Cancer Res Ther; 2019; 15(7):1477-1483. PubMed ID: 31939425
[TBL] [Abstract] [Full Text] [Related]
8. Safe and effective use of nivolumab for treating lung adenocarcinoma associated with sporadic lymphangioleiomyomatosis: a rare case report.
Pluvy J; Brosseau S; Stelianides S; Danel C; Nguenang M; Khalil A; Crestani B; Zalcman G; Gounant V
BMC Pulm Med; 2019 Jan; 19(1):12. PubMed ID: 30634951
[TBL] [Abstract] [Full Text] [Related]
9. Establishment of Slice Cultures as a Tool to Study the cancer Immune Microenvironment.
Jiang X; Seo YD; Sullivan KM; Pillarisetty VG
Methods Mol Biol; 2019; 1884():283-295. PubMed ID: 30465211
[TBL] [Abstract] [Full Text] [Related]
10. Genomic landscape of ovarian clear cell carcinoma via whole exome sequencing.
Kim SI; Lee JW; Lee M; Kim HS; Chung HH; Kim JW; Park NH; Song YS; Seo JS
Gynecol Oncol; 2018 Feb; 148(2):375-382. PubMed ID: 29233531
[TBL] [Abstract] [Full Text] [Related]
11. Vaccination with inhibin-α provides effective immunotherapy against testicular stromal cell tumors.
Aguilar R; Johnson JM; Barrett P; Tuohy VK
J Immunother Cancer; 2017; 5():37. PubMed ID: 28428886
[TBL] [Abstract] [Full Text] [Related]
12. mTOR promotes pituitary tumor development through activation of PTTG1.
Chen R; Duan J; Li L; Ma Q; Sun Q; Ma J; Li C; Zhou X; Chen H; Jing Y; Zhao S; Wu X; Zhang H
Oncogene; 2017 Feb; 36(7):979-988. PubMed ID: 27524416
[TBL] [Abstract] [Full Text] [Related]
13. Death-associated protein kinase 1 promotes growth of p53-mutant cancers.
Zhao J; Zhao D; Poage GM; Mazumdar A; Zhang Y; Hill JL; Hartman ZC; Savage MI; Mills GB; Brown PH
J Clin Invest; 2015 Jul; 125(7):2707-20. PubMed ID: 26075823
[TBL] [Abstract] [Full Text] [Related]
14. Neurogenin 3-directed cre deletion of tsc1 gene causes pancreatic acinar carcinoma.
Ding L; Han L; Li Y; Zhao J; He P; Zhang W
Neoplasia; 2014 Nov; 16(11):909-17. PubMed ID: 25425965
[TBL] [Abstract] [Full Text] [Related]
15. The anti-tumor activator sMEK1 and paclitaxel additively decrease expression of HIF-1α and VEGF via mTORC1-S6K/4E-BP-dependent signaling pathways.
Kim BR; Yoon K; Byun HJ; Seo SH; Lee SH; Rho SB
Oncotarget; 2014 Aug; 5(15):6540-51. PubMed ID: 25153728
[TBL] [Abstract] [Full Text] [Related]
16. Adamantinomatous craniopharyngiomas express tumor stem cell markers in cells with activated Wnt signaling: further evidence for the existence of a tumor stem cell niche?
Hölsken A; Stache C; Schlaffer SM; Flitsch J; Fahlbusch R; Buchfelder M; Buslei R
Pituitary; 2014 Dec; 17(6):546-56. PubMed ID: 24356780
[TBL] [Abstract] [Full Text] [Related]
17. Pancreatic neuroendocrine tumor in a child with a tuberous sclerosis complex 2 (tsc2) mutation.
Bombardieri R; Moavero R; Roberto D; Cerminara C; Curatolo P
Endocr Pract; 2013; 19(5):e124-8. PubMed ID: 23757617
[TBL] [Abstract] [Full Text] [Related]
18. Extrarenal perivascular epithelioid cell tumors (PEComas) respond to mTOR inhibition: clinical and molecular correlates.
Dickson MA; Schwartz GK; Antonescu CR; Kwiatkowski DJ; Malinowska IA
Int J Cancer; 2013 Apr; 132(7):1711-7. PubMed ID: 22927055
[TBL] [Abstract] [Full Text] [Related]
19. Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine.
Koulouri O; Auldin MA; Agarwal R; Kieffer V; Robertson C; Falconer Smith J; Levy MJ; Howlett TA
Clin Endocrinol (Oxf); 2011 Jun; 74(6):744-9. PubMed ID: 21521256
[TBL] [Abstract] [Full Text] [Related]
20. Pancreatic neuroendocrine tumors: role of novel agents. Highlights from the "2011 ASCO Gastrointestinal cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
Strimpakos AS; Syrigos KN; Saif MW
JOP; 2011 Mar; 12(2):117-9. PubMed ID: 21386634
[TBL] [Abstract] [Full Text] [Related]
[Next]
